Characterization of Circulating T Cell Receptor Repertoire Provides Information about Clinical Outcome after PD-1 Blockade in Advanced Non-Small Cell Lung Cancer Patients

SIMPLE SUMMARY: Immune checkpoint blockers (ICBs) have demonstrated durable anti-tumor responses in advanced non-small cell lung cancer (NSCLC). Despite progress in development of new predictive biomarkers, such as PD-L1 expression, TMB, or MSI, there is still an urge for a better selection of patie...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Cancers (Basel)
Hoofdauteurs: Dong, Ning, Moreno-Manuel, Andrea, Calabuig-Fariñas, Silvia, Gallach, Sandra, Zhang, Feiyu, Blasco, Ana, Aparisi, Francisco, Meri-Abad, Marina, Guijarro, Ricardo, Sirera, Rafael, Camps, Carlos, Jantus-Lewintre, Eloísa
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: MDPI 2021
Onderwerpen:
Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC8231221/
https://ncbi.nlm.nih.gov/pubmed/34204662
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13122950
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items